Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
Kidney Int. 2013 Feb;83(2):316-22. doi: 10.1038/ki.2012.349. Epub 2012 Sep 26.
Mutations in the inverted formin 2 gene (INF2) have recently been identified as the most common cause of autosomal dominant focal and segmental glomerulosclerosis (FSGS). To quantify the contribution of various genes contributing to FSGS, we sequenced INF2 where all mutations have previously been described (exons 2 to 5) in a total of 215 probands and 281 sporadic individuals with FSGS, along with other known genes accounting for autosomal dominant FSGS (ACTN4, TRPC6, and CD2AP) in 213 probands. Variants were classified as disease-causing if they altered the amino acid sequence and if they were not found in control samples and in families segregated with disease. Mutations in INF2 were found in a total of 20 of the 215 families (including those previously reported) in our cohort of autosomal dominant familial nephrotic syndrome or FSGS, thereby explaining disease in 9%. INF2 mutations were found in 2 of 281 individuals with sporadic FSGS. In contrast, ACTN4- and TRPC6-related diseases accounted for 3 and 2% of our familial cohort, respectively. INF2-related disease showed variable penetrance, with onset of disease ranging widely from childhood to adulthood, and commonly leading to end-stage renal disease in the third and fourth decade of life. Thus, mutations in INF2 are a more common, although still a minor, monogenic cause of familial FSGS when compared with other known autosomal dominant genes associated with FSGS.
最近,反向形态发生因子 2 基因 (INF2) 的突变被确定为常染色体显性局灶节段性肾小球硬化症 (FSGS) 的最常见原因。为了量化导致 FSGS 的各种基因的贡献,我们对 INF2 进行了测序,所有先前描述的突变(外显子 2 至 5)都在总共 215 名 FSGS 先证者和 281 名散发性个体以及 213 名先证者中的其他已知导致常染色体显性 FSGS 的基因(ACTN4、TRPC6 和 CD2AP)中进行了测序。如果变异改变了氨基酸序列,并且在对照样本和与疾病分离的家族中未发现,则将其归类为致病变异。在我们的常染色体显性家族性肾病综合征或 FSGS 队列中,总共在 215 个家族中的 20 个家族(包括先前报道的家族)中发现了 INF2 突变,因此解释了 9%的疾病。在 281 名散发性 FSGS 个体中发现了 2 名存在 INF2 突变。相比之下,ACTN4 和 TRPC6 相关疾病分别占我们家族队列的 3%和 2%。INF2 相关疾病的外显率不同,疾病发病范围从儿童期到成年期不等,通常在生命的第三和第四个十年导致终末期肾病。因此,与其他与 FSGS 相关的已知常染色体显性基因相比,INF2 突变是 FSGS 的一种更为常见但仍然是次要的单基因病因。